STAT3 and breast carcinoma: We investigated the antitumor effects of the azetidine analogs by treating human breast cancer MDA-MB-231 and MDA-MB-468 lines harboring aberrantly-active Stat3 with increasing concentrations of H105, H120, H172, or H182 for 72 h and performing CyQuant assay for viable cell numbers [13].